Sugi Predict

Sugi Predict / Compounds / SCHEMBL70348

SCHEMBL70348

SCHEMBL70348

CC1(C)c2ccccc2-c2ccc(B3OC(C)(C)C(C)(C)O3)cc21

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LPL P06858 13/20 0.49
▸ LIPG Q9Y5X9 13/20 0.49
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA9 Q16790 2/20 0.39
▸ PRMT5 O14744 1/20 0.39
▸ WDR77 Q9BQA1 1/20 0.39
▸ P4HB P07237 1/20 0.37
▸ ROCK1 Q13464 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA3 P07451 1/20 0.36
▸ CA4 P22748 1/20 0.36
▸ CA6 P23280 1/20 0.36
▸ CA5A P35218 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CA14 Q9ULX7 1/20 0.36
▸ CA5B Q9Y2D0 1/20 0.36
▸ BACE1 P56817 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29674722 1.00 LPL (0.49) LPLLIPGCA1CA2CA9
SCHEMBL29450660 1.00 LPL (0.49) LPLLIPGCA1CA2CA9
SCHEMBL431646 0.94 LIPG (0.51) LPLLIPGCA1CA2CA9
SCHEMBL430244 0.94 LIPG (0.51) LPLLIPGCA1CA2CA9
SCHEMBL17645471 0.92 LPL (0.45) LPLLIPGCA1CA2CA9
SCHEMBL17656926 0.92 LIPG (0.49) LPLLIPGCA1CA2CA9
SCHEMBL69358 0.92 LIPG (0.47) LPLLIPGCA1CA2CA9
SCHEMBL18371831 0.91 LPL (0.46) LPLLIPGCA1CA2CA9
SCHEMBL10018883 0.90 LPL (0.49) LPLLIPGCA1CA2CA9
SCHEMBL29639987 0.90 LPL (0.49) LPLLIPGCA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113336622-B Fluorene derivative with AIE characteristic, preparation method and application 辽宁师范大学 2022-06-10 — — CN claimed
CN-113336622-A Fluorene derivative with AIE characteristic, preparation method and application 辽宁师范大学 2021-09-03 — — CN claimed
CN-105732680-B A kind of BODIPY derivatives of middle position alkoxyl phenyl substitution and the substitution of 2,6 strong donor residues and preparation method thereof 东莞理工学院 2017-12-08 — — CN claimed
CN-105732680-A Median alkoxy phenyl substituted and 2, 6 site strong electron donating group substituted BODIPY (4,4'-difluoro-4-bora-3a,4a-diaza-sindacene) derivative and preparation method thereof 东莞理工学院 2016-07-06 — — CN claimed
US-12421215-B2 Heterocyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2025-09-23 — — US disclosed
US-20250241202-A1 OPTOELECTRONIC DEVICE AND ELECTRONIC APPARATUS INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2025-07-24 — — US disclosed
WO-2025127695-A1 ORGANIC ELECTROLUMINESCENT DEVICE 솔루스첨단소재 주식회사 2025-06-19 — — WO disclosed
US-20250179104-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2025-06-05 — — US disclosed
WO-2024151024-A1 COMPOUND FOR CAPPING LAYER AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 진웅산업 2024-07-18 — — WO disclosed
WO-2024144208-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 솔루스첨단소재 주식회사 2024-07-04 — — WO disclosed
WO-2024144190-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 솔루스첨단소재 주식회사 2024-07-04 — — WO disclosed
WO-2024144190-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 솔루스첨단소재 주식회사 2024-07-04 — — WO disclosed
US-20080161574-A1 DIAZAFLUORENE COMPOUND CANON KABUSHIKI KAISHA (JP) 2008-07-03 — — US disclosed
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2008-06-26 — — US disclosed
US-20080119671-A1 PYRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2008-05-22 — — US disclosed
US-20080119671-A1 PYRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2008-05-22 — — US disclosed
US-20070257603-A1 FLUORENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND CANON KABUSHIKI KAISHA (JP) 2007-11-08 — — US disclosed
US-20070257603-A1 FLUORENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND CANON KABUSHIKI KAISHA (JP) 2007-11-08 — — US disclosed
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 — — US disclosed
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161574-A1 DIAZAFLUORENE COMPOUND AFF1, NPFFR1, AFF2 LPL 4328/4885LIPG 4352/4885CA1 1302/4885
US-20070257603-A1 FLUORENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND FLI1, AFF2, AFF1 LPL 1251/4885LIPG 1359/4885CA1 4280/4885
US-20070122652-A1 Compound and organic electroluminescent device using same OR10J3, LEF1, RPL19 LPL 2045/4885LIPG 1398/4885CA1 3092/4885
US-20080119671-A1 PYRENE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE AHR, CYP1A1, ARNT LPL 3508/4885LIPG 4480/4885CA1 4715/4885
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE AZI2, CYP1A2, CYP2C19 LPL 2008/4885LIPG 2246/4885CA1 2225/4885
US-12421215-B2 Heterocyclic compound and organic light emitting device comprising the same CRY1, CYP1A1, CYP1B1 LPL 3341/4885LIPG 3579/4885CA1 3049/4885
US-20250179104-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT TPR, OCIAD1, OCIAD2 LPL 3309/4885LIPG 4215/4885CA1 2994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.